Evidence map›Paper›PMID 23095658›Full record

ArticleNeuroepidemiology2013

Age of onset: can we rely on essential tremor patients to report this? Data from a prospective, longitudinal study.

Elan D Louis

Abstract read
In one paragraph

Article in Neuroepidemiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Developing a Staging Scheme for Essential Tremor: A Discussion of Organizing Principles.Tremor and other hyperkinetic movements (New York, N.Y.) · 2023
    Article
  2. Diagnosis and Treatment of Essential Tremor.Continuum (Minneapolis, Minn.) · 2022
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Medication non-adherence in essential tremor.Parkinsonism & related disorders · 2015
    Article
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Elan D LouisDepartment of Neurology, College of Physicians and Surgeons, Mailman School of Public Health, Columbia University, New York, NY, USA. EDL2@columbia.edu

Funding

ENVIRONMENTAL EPIDEMIOLOGY OF ESSENTIAL TREMORR01NS039422 · NINDS · YALE UNIVERSITY · PI LOUIS, ELAN D · 2000 to 2013
$7.7M
NINDS NIH HHS R01 NS039422
6 · The paper itself

Abstract

backgroundEssential tremor (ET) is among the most prevalent neurological diseases. Age of onset, a key variable in neuroepidemiological and genetic research, is chiefly assessed by self-report rather than medical record review; the latter may be of little use. As a researcher, one wonders about the quality of this self-report. Is age of onset something which can be reproducibly self-reported by patients? There are few published data to aid researchers.

methodsAge of onset was self-reported at two time points (baseline and follow-up) in 86 ET cases in a longitudinal epidemiological study in New York.

resultsThe mean follow-up interval was 5.7 ± 2.5 (maximum = 14) years. Overall, agreement between the baseline and follow-up reports was high (ρ = 0.85, p < 0.001). Yet the difference (age of onset (baseline) - age of onset (follow-up)) ranged widely (from -47 to 32 years), and in one fifth of cases was ≥ 10 years. Greater agreement was associated with several clinical factors including age, medication use, embarrassment, depressive symptoms, cognitive test score and disease duration.

conclusionsDifferences in reported age of onset in ET may vary widely, and in up to one fifth of patients may be substantial. Investigators should approach these self-reports with caution.

Indexed as

AgedAge FactorsAge of OnsetConnecticutEducational StatusEssential TremorFemaleFollow-Up StudiesHumansLongitudinal StudiesMaleNew JerseyNew YorkProspective StudiesReproducibility of ResultsSelf Report

Identifiers

PMID23095658
PMCPMC4035216

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.